Pioneer Pharma (singapore) Pte. Ltd. - Net Worth and Insider Trading
Pioneer Pharma (singapore) Pte. Ltd. Net Worth
The estimated net worth of Pioneer Pharma (singapore) Pte. Ltd. is at least $232 dollars as of 2024-09-21. Pioneer Pharma (singapore) Pte. Ltd. is the 10% Owner of NovaBay Pharmaceuticals Inc and owns about 313 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $232. Details can be seen in Pioneer Pharma (singapore) Pte. Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pioneer Pharma (singapore) Pte. Ltd. has not made any transactions after 2015-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pioneer Pharma (singapore) Pte. Ltd.
Pioneer Pharma (singapore) Pte. Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pioneer Pharma (singapore) Pte. Ltd. owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .
Insider Ownership Summary of Pioneer Pharma (singapore) Pte. Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBY | NovaBay Pharmaceuticals Inc | 2015-03-03 | 10 percent owner |
Pioneer Pharma (singapore) Pte. Ltd. Latest Holdings Summary
Pioneer Pharma (singapore) Pte. Ltd. currently owns a total of 1 stock. Pioneer Pharma (singapore) Pte. Ltd. owns 313 shares of NovaBay Pharmaceuticals Inc (NBY) as of March 3, 2015, with a value of $232.
Latest Holdings of Pioneer Pharma (singapore) Pte. Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals Inc | 2015-03-03 | 313 | 0.74 | 232 |
Holding Weightings of Pioneer Pharma (singapore) Pte. Ltd.
Pioneer Pharma (singapore) Pte. Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Pioneer Pharma (singapore) Pte. Ltd. has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 85 shares on March 3, 2015, which cost Pioneer Pharma (singapore) Pte. Ltd. around $2 Million.
Insider Trading History of Pioneer Pharma (singapore) Pte. Ltd.
- 1
Pioneer Pharma (singapore) Pte. Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Pioneer Pharma (singapore) Pte. Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pioneer Pharma (singapore) Pte. Ltd. is 9.09%. GuruFocus also compares Pioneer Pharma (singapore) Pte. Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Pioneer Pharma (singapore) Pte. Ltd. within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pioneer Pharma (singapore) Pte. Ltd.'s insider trading performs compared to the benchmark.
Performance of Pioneer Pharma (singapore) Pte. Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.71 | | | | | |
| Relative Return to S&P 500(%) | 17.68 | | | | | |
Pioneer Pharma (singapore) Pte. Ltd. Ownership Network
Pioneer Pharma (singapore) Pte. Ltd. Owned Company Details
What does NovaBay Pharmaceuticals Inc do?
Who are the key executives at NovaBay Pharmaceuticals Inc?
Pioneer Pharma (singapore) Pte. Ltd. is the 10 percent owner of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .
NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovaBay Pharmaceuticals Inc Insider Transactions
Pioneer Pharma (singapore) Pte. Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Pioneer Pharma (singapore) Pte. Ltd.. You might contact Pioneer Pharma (singapore) Pte. Ltd. via mailing address: 33a Chander Road, Singapore U0 219539.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
